As of Jun 2, 2026, the XOMA stock has a PE ratio of 25.27. The calculation is based on the latest EPS of $1.65 and the stock price of $41.69 per share.
The mean historical PE ratio of XOMA over the last ten years is 40.58. The current 25.27 P/E ratio is 38% lower than the historical average. Looking back at the last ten years, XOMA's PE ratio peaked in the Sep 2021 quarter at 130.26, with a price of $24.75 and an EPS of $0.19. The Mar 2018 quarter marked the lowest point at 13.67, with a price of $20.23 and an EPS of $1.48.
Maximum annual decrease: -43.85% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 17.38 | N/A | $26.59 | $1.53 |
| 2024 | N/A | N/A | $26.28 | -$1.65 |
| 2023 | N/A | N/A | $18.5 | -$4.04 |
| 2022 | N/A | N/A | $18.4 | -$1.98 |
| 2021 | 30.22 | -43.85% | $20.85 | $0.69 |
| 2020 | 53.82 | N/A | $44.13 | $0.82 |
| 2019 | N/A | N/A | $27.3 | -$0.23 |
| 2018 | N/A | N/A | $12.65 | -$1.59 |
| 2017 | 47.47 | N/A | $35.6 | $0.75 |
| 2016 | N/A | N/A | $4.22 | -$8.89 |
| 2015 | N/A | N/A | $26.6 | -$3.5 |
| 2014 | N/A | N/A | $71.8 | -$7.13 |
| 2013 | N/A | N/A | $134.6 | -$28.6 |
| 2012 | N/A | N/A | $48 | -$22 |
| 2011 | N/A | N/A | $23 | -$20.8 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 19.01 | 9.38% | $31.37 | $1.65 |
| Dec 2025 | 17.38 | -63.47% | $26.59 | $1.53 |
| Sep 2025 | 47.58 | N/A | $38.54 | $0.81 |
| Jun 2025 | N/A | N/A | $25.2 | -$1.52 |
| Mar 2025 | N/A | N/A | $19.93 | -$1.1 |
| Dec 2024 | N/A | N/A | $26.28 | -$1.65 |
| Sep 2024 | N/A | N/A | $26.48 | -$3.44 |
| Jun 2024 | N/A | N/A | $23.69 | -$2.45 |
| Mar 2024 | N/A | N/A | $24.05 | -$3.92 |
| Dec 2023 | N/A | N/A | $18.5 | -$4.04 |
| Sep 2023 | N/A | N/A | $14.09 | -$2.81 |
| Jun 2023 | N/A | N/A | $18.89 | -$2.69 |
| Mar 2023 | N/A | N/A | $21.11 | -$2.63 |
| Dec 2022 | N/A | N/A | $18.4 | -$1.98 |
| Sep 2022 | 20.12 | -22.35% | $17.91 | $0.89 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
XOMA's current PE ratio is lower than its 5 and 10-year averages.
XOMA's price to earnings (P/E) of 25.27 is higher than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 23.23, XOMA's price to earnings (P/E) is 9% higher.
In comparison to its peers LLY and ABBV, XOMA's PE ratio is lower, but it is higher than NVS's and PFE's. XOMA's PE ratio is trading above the peer average of 23.2.
| Stock name | PE ratio | Market cap |
|---|---|---|
| REGN Regeneron Pharmaceuticals Inc | 14.54 | $64.89B |
| PFE Pfizer Inc | 19.34 | $144.42B |
| NVS Novartis AG | 20.46 | $274.12B |
| TEVA Teva Pharmaceutical Industries Ltd | 23.96 | $38.23B |
| XOMA XOMA Corp | 25.27 | $522.96M |
| LLY ELI LILLY & Co | 38.27 | $1.02T |
| ABBV AbbVie Inc | 106.96 | $383.62B |
| EBS Emergent BioSolutions Inc | N/A | $409.16M |
As of Jun 2, 2026, XOMA stock has a price to earnings ratio of 25.27.
The average PE ratio for XOMA stock over the past 5 years is 41.45.
Over the last ten years, the quarterly PE ratio reached its highest level at 130.26 in the Sep 2021 quarter.
XOMA's current price to earnings ratio is 38% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 2, 2026), XOMA's share price is $41.69. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.65. Therefore, XOMA's PE ratio for today is 25.27. PE RATIO(25.27) = STOCK PRICE($41.69) / TTM EPS($1.65)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.